Editors for Human Biology and Medicine

We aim to publish studies that use diverse methodologies to robustly define pathogenic mechanisms and/or creatively leverage such information to conceive of, rigorously test, and/or most effectively implement treatment strategies with broad relevance to human health and disease. Our interests include epidemiological and natural history studies, disease modeling, and randomized clinical trials that have the strong potential to impact public health or to address unmet patient needs in areas that include, but are not limited to, cancer, cardiovascular medicine and infectious or orphan diseases. We also welcome studies in all areas of human genetics that explore traits of broad relevance to health and disease. Read the latest research in this subject area.

Senior editors

  1. Charles Sawyers

    Charles Sawyers

    Memorial Sloan-Kettering Cancer Center, United States

    Charles Sawyers is an Investigator of the Howard Hughes Medical Institute and the Director of the Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center. His studies of BCR-ABL tyrosine kinase function in chronic myeloid leukemia, in collaboration with Brian Druker and Novartis, led to the development of the kinase inhibitor imatinib as primary therapy for CML. This was followed by his discovery that BCR-ABL kinase domain mutations confer imatinib resistance, and development of the second generation Abl kinase inhibitor dasatinib, in collaboration with Bristol Myers Squibb. Sawyers' current work in prostate cancer resulted in the novel antiandrogen enzalutamide (MDV3100), discovered in collaboration with University of California, Los Angeles chemist Michael Jung, which received FDA approval in 2012. Sawyers is a member of the National Academy of Sciences and the Institute of Medicine and co-recipient of the 2009 Lasker~DeBakey Clinical Medical Research Award.

    Expertise
    Cancer Biology
    Human Biology and Medicine
    Research focus
    oncology and translational medicine
    oncology
    translational medicine
    Competing interests statement
    Charles Sawyers receives research funding from the Howard Hughes Medical Institute, the National Cancer Institute, the Starr Cancer Consortium, Stand Up to Cancer, and the Prostate Cancer Foundation. He is President Elect of the American Association of Cancer Research and will serve as President from 2013–14. He is a Councilor of the American Association of Physicians (until 2017) and serves on the editorial boards of Cell and Cancer Cell, and as a scientific advisor to Agios, Aragon, Aveo, Housey Pharmaceuticals, Merck, Nextech, Pfizer, and Tracon.
  2. Prabhat Jha

    Prabhat Jha

    Saint Michael's Hospital, Canada

    Prabhat Jha has been a key figure in epidemiology and economics of global health for the past decade. He is the University of Toronto Endowed Professor in Disease Control and Canada Research Chair at the Dalla Lana School of Public Health, and the founding Director of the Centre for Global Health Research at St. Michael's Hospital in Toronto. Professor Jha is a lead investigator of the Million Death Study in India, which quantifies the causes of premature mortality in over one million homes from 1997–2014 and which examines the contribution of key risk factors such as tobacco, alcohol, diet, and environmental exposures. He is co-investigator of the Disease Control Priorities Network and the author of several influential books on tobacco control, including two that helped enable a global treaty on tobacco control, now signed by over 160 countries. Prior to founding CGHR, Professor Jha served as Senior Scientist for the World Health Organization, where he co-led the work on health and poverty for the Commission on Macroeconomics and Health. Earlier, he headed the World Bank team responsible for developing the Second National HIV/AIDS Control Program in India. His advisory work has included the Government of South Africa on its national health insurance plan, and the United States Institute of Medicine on global health. Notable recognitions include the Order of Canada (2013) for contributions to global health, the Luther Terry Award for Research on Tobacco Control (2012), The Globe and Mail 25 Transformational Canadians (2010), Top 40 Canadians under Age 40 Award (2004), the Ontario Premier’s Research Excellence Award (2004), and Gold Medal from the Poland Health Promotion Foundation (2000). Professor Jha holds an MD from the University of Manitoba and a DPhil from Oxford University, where he studied as a Canadian Rhodes Scholar.

    Expertise
    Epidemiology and Global Health
    Microbiology and Infectious Disease
    Human Biology and Medicine
    Research focus
    epidemiology
    global health
    infectious disease and population dynamics
    randomized controlled trials
    Competing interests statement
    Prabhat Jha has received funding from the Bill and Melinda Gates Foundation, Canadian International Development Research Agency, Canadian International Development Agency, the International Science and Technology Program of the Canadian government, and the US National Institutes of Health. He serves on the editorial board of Demography India. He advises several agencies and the Canadian government on epidemiology, disease control strategies, and tobacco control, and serves on the advisory board of the UK Biobank.
  3. Huda Zoghbi

    Huda Zoghbi

    Texas Children's Hospital, United States

    Huda Zoghbi is Professor of Pediatrics, Neurology, Molecular and Human Genetics, and Neuroscience at Baylor College of Medicine, Houston, Texas. She is also an Investigator with the Howard Hughes Medical Institute and Director of the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital. Her research focuses on understanding normal brain development and on elucidating the pathogenesis of several neurological disorders including the autism spectrum disorder, Rett syndrome, and late-onset neurodegenerative diseases.

    Expertise
    Human Biology and Medicine
    Neuroscience
    Research focus
    animal models of human disease and behavioural sciences
    neurodegenerative disorders
    polyglutamine disorders
    autism
    synaptic disorders
    neurogenetics
    Experimental organism
    human
    Competing interests statement
    Huda Zoghbi is actively receiving funds from the Howard Hughes Medical Institute, the National Institutes of Health, Rett Syndrome Research Trust, International Rett syndrome Foundation (and she is a member of advisory panels for all 4 organizations), Baylor College of Medicine, and Texas Children’s Hospital. She is Associate Editor of Annual Reviews of Neuroscience and a member of the editorial team of Cell and Neuron. She is Vice-Chair of the McKnight Neuroscience Fund and a member of the following Scientific Advisory Panels: the Jane Coffin Childs Fund, Gruber Genetics Prize Jury, Janssen Prize Jury, Lasker Jury, and Vilcek Prize Jury. She was an elected member at large of the 2015 Class Membership Committee of the National Academy of Sciences.
  4. Mark McCarthy

    Mark McCarthy

    University of Oxford, United Kingdom

    Mark McCarthy is the Robert Turner Professor of Diabetes Medicine at the University of Oxford, based at the Oxford Centre for Diabetes, Endocrinology, and Metabolism and the Wellcome Trust Centre for Human Genetics. He is also a Consultant Physician at the Oxford University Hospitals Trust and is currently Visiting Professor at the University of Geneva. Following medical training in Cambridge and London, a spell as an MRC Travelling Fellow at the Whitehead Institute in Massachusetts, and 8 years at Imperial College, he moved to Oxford in 2002. He is a physician-scientist and human geneticist interested in the biological basis of complex disease. His research group is focused on the identification and characterisation of genetic variants influencing risk of type 2 diabetes and related traits, and on using those discoveries to drive biological inference and translational opportunities. He works closely with colleagues in Oxford and beyond to establish the mechanisms whereby T2D-risk variants influence islet function, and to explore the value of this information to drive clinical advances. He has played a major role in establishing and leading a number of the global initiatives in this field including the DIAGRAM, MAGIC, GIANT, EGG, GoT2D, ENGAGE, and T2D-GENES consortia. He has been a Senior Editor at eLife since 2015.

    Expertise
    Genetics and Genomics
    Human Biology and Medicine
    Research focus
    genetics
    metabolism
    genome wide association and resequencing studies
    systems biology
    human genetics and genomics
    multifactorial disease
    metabolic disease
    biomarkers
    Experimental organism
    human
    Competing interests statement
    Mark McCarthy has received funding from the UK Medical Research Council, Wellcome Trust, Diabetes UK, British Heart Foundation, the (UK) National Institute for Health Research, the (US) National Institutes of Health, the European Commission, the Foundation of the NIH, the Juvenile Diabetes Research Foundation, and from the Innovative Medicines Initiative. He is a member of the Scientific Advisory Boards (or equivalent advisory committees) for the Wellcome Trust Sanger Institute (Human Genetics), the H3A Bionet, and Genome Quebec. He is a member of the MRC Population and Systems Medicine Board and Cross Board Cohort Advisory Group. He has, via the IMI, received research funding, and/or has research collaborations with multiple pharma companies including Pfizer, Lilly, Sanofi-Aventis, NovoNordisk, and Boehringer Ingelheim.
  5. Harry Dietz

    Harry Dietz

    Howard Hughes Medical Institute and Institute of Genetic Medicine, Johns Hopkins University School of Medicine, United States

    Dr Dietz is Victor A McKusick Professor of Pediatrics, Medicine, and Molecular Biology & Genetics in the Institute of Genetic Medicine at the Johns Hopkins University School of Medicine. He is also an Investigator at the Howard Hughes Medical Institute. His undergraduate training in biomedical engineering was performed at Duke University and his MD degree was received from the Health Sciences University of Syracuse. Clinical and research training in pediatrics, pediatric cardiology, and genetics occurred at Johns Hopkins University School of Medicine. Dr Dietz’s research is focused on elucidation of the etiology and pathogenesis of connective tissue disorders that involve the cardiovascular system. Dr Dietz has received multiple prestigious awards including the Curt Stern Award from the American Society of Human Genetics, the Taubman Prize for excellence in translational medical science, and the Harrington Prize from the American Society for Clinical Investigation and the Harrington Discovery Institute. He is an inductee of the American Society for Clinical Investigation, American Association for the Advancement of Science, Academy of American Physicians, The National Academy of Medicine, Association of American Physicians, and the National Academy of Sciences.

    Expertise
    Human Biology and Medicine
    Genetics and Genomics
    Research focus
    human genetics
    extracellular matrix
    connective tissue disorders
    genetics of cardiovascular disease
    Competing interests statement
    Hal Dietz receives funding from the Howard Hughes Medical Institute, National Institutes of Heath, Leducq Foundation, Marfan Foundation, and Scleroderma Research Foundation. He currently serves on the editorial board of Science Translation Medicine and the Journal of Clinical Investigation. He serves on the advisory board of GlaxoSmithKline, is founder and consultant for Blade Therapeutics, and also consults for Eli Lilly and Bristol-Myers Squibb. He is President Elect of the American Society of Human Genetics.
  6. Gary Westbrook

    Vollum Institute, United States

    Gary Westbrook is a Senior Scientist and Co-Director of the Vollum Institute and Rocky and Julie Dixon Professor of Neurology at Oregon Health and Science University. Dr Westbrook is a member of the National Academy of Medicine (formerly Institute of Medicine), the American Academy of Arts and Sciences, and past editor-in-chief of the Journal of Neuroscience. He has received Javits and Merit awards from NIH for his research as well as an International Cooperation Award from the Max Planck Society. Dr Westbrook received his medical training and did graduate study in Biomedical Engineering at Case Western Reserve University, followed by residencies in Internal Medicine and Neurology, and basic neuroscience research at the National Institutes of Health in Bethesda. Earlier work in his lab was mostly directed at the level of receptors, particularly N-methyl-D-aspartate (NMDA) receptors, and the function of single synapses. The emphasis has now largely shifted to studies of small networks (microcircuits) in the hippocampus and olfactory system. Dr Westbrook maintains interests in clinical neurology, particularly epilepsy, as well as graduate research training – he currently serves as the director of the Neuroscience Graduate Program at Vollum/OHSU.

    Expertise
    Neuroscience
    Human Biology and Medicine
    Research focus
    clinical neurology
    synaptic transmission
    olfactory system
    hippocampus
    neuroscience
    brain microcircuits
    neurological diseases
    Experimental organism
    mouse
    Competing interests statement
    Gary Westbrook is employed by Oregon Health and Science University. He receives research and training funding from the National Institutes of Health and the Ellison Medical Foundation. He is a member of the National Academy of Medicine (formerly Institute of Medicine) and the American Academy of Arts and Sciences. He serves on Scientific Advisory Boards for Max Planck Institutes in Göttingen (MPIEM) and Florida (MPFI), the Myelin Repair Foundation, and on study sections for the National Institutes of Health. He is currently a member of editorial boards for Physiological Reviews and Philosophical Transactions of the Royal Society B.
  7. Wendy S Garrett

    Wendy S Garrett

    Harvard T.H. Chan School of Public Health, United States

    Wendy Garrett is the Melvin J and Geraldine L. Glimcher Associate Professor of Immunology and Infectious Diseases at the Harvard T. H. Chan School of Public Health and an Associate Member of the Broad Institute. Her work explores host-microbiota interactions underlying mucosal immune homeostasis, gastrointestinal inflammatory disorders, and cancer. She graduated from the Yale College; received her MD PhD from Yale University and completed post-graduate training at Harvard.

    Expertise
    Immunology and Inflammation
    Microbiology and Infectious Disease
    Human Biology and Medicine
    Research focus
    host-microbiota interactions
    microbiome
    mucosal immunology
    Competing interests statement
    Wendy Garrett receives funding from the National Institutes of Health, Hoffman-LaRoche, and Groupe Danone. She is a member of the Cell Reports and Journal of Clinical Microbiology editorial boards. She consults for Janssen and serves on the scientific advisory boards of Synlogic and Evelo Biosciences.

Reviewing editors

  1. Jonathan Flint

    University of California, Los Angeles, United States

    Expertise
    Genetics and Genomics
    Human Biology and Medicine
    Research focus
    genetics
    psychiatric disorders
  2. Jos WM van der Meer

    Radboud University Medical Centre, Netherlands

    Expertise
    Human Biology and Medicine
    Research focus
    infectious disease and host defense
    innate immunity
    trained immunity
    immunodeficiency
    autoinflammatory diseases
    chronic fatigue syndrome
  3. Michael Czech

    University of Massachusetts Medical School, United States

    Expertise
    Cell Biology
    Human Biology and Medicine
    Research focus
    insulin
    metabolism
    lipid-protein interactions
    signal transduction
    membranes
    adipose
    obesity
    insulin resistance
    diabetes
  4. Dominique Soldati-Favre

    University of Geneva, Switzerland

    Expertise
    Human Biology and Medicine
    Microbiology and Infectious Disease
    Research focus
    host-parasite interactions
    apicomplexa biology
    motility
    Experimental organism
    toxoplasma gondii
    plasmodium
  5. Joaquin Espinosa

    University of Colorado Denver School of Medicine, United States

    Expertise
    Cancer Biology
    Cell Biology
    Human Biology and Medicine
    Research focus
    apoptosis
    p53
    tumor suppressors
    cancer biology
  6. Ralph J DeBerardinis

    University of Texas Southwestern Medical Center, United States

    Expertise
    Cancer Biology
    Cell Biology
    Human Biology and Medicine
    Research focus
    cancer
    metabolism
    medicine
    genetics
    Experimental organism
    human
    mouse
  7. Joan Massagué

    Memorial Sloan Kettering Cancer Center, United States

    Expertise
    Cancer Biology
    Cell Biology
    Human Biology and Medicine
    Research focus
    signaling
    cell fate
    tumor heterogeneity
    metastasis
    Experimental organism
    human tissue
  8. Tonu Esko

    University of Tartu, Estonia

    Expertise
    Human Biology and Medicine
    Genetics and Genomics
    Research focus
    complex diseases
    Experimental organism
    human
  9. Duojia Pan

    UT Southwestern Medical Center, United States

    Expertise
    Cancer Biology
    Cell Biology
    Human Biology and Medicine
    Research focus
    signal transduction
    growth control
    cancer biology
    Experimental organism
    Drosophila
  10. Clifford Rosen

    Maine Medical Center Research Institute, United States

    Expertise
    Human Biology and Medicine
    Research focus
    skeletal biology
    bone disease
    Experimental organism
    mouse
  11. Suzanne R Pfeffer

    Stanford University, United States

    Expertise
    Cell Biology
    Human Biology and Medicine
    Research focus
    membrane traffic
    endosomes
    lysosomes
    golgi complex
    secretory pathway
  12. Jamey Marth

    University of California, Santa Barbara, United States

    Expertise
    Cell Biology
    Human Biology and Medicine
    Research focus
    glycobiology
    protein glycosylation
    cell biology of disease
  13. Peter Tontonoz

    University of California, Los Angeles, United States

    Expertise
    Cell Biology
    Human Biology and Medicine
    Research focus
    nuclear receptors
    lipid metabolism
    obesity/diabetes
    atherosclerosis
  14. Jody Rosenblatt

    University of Utah, United States

    Expertise
    Cell Biology
    Human Biology and Medicine
    Cancer Biology
    Research focus
    apoptosis
    mitosis
    cell extrusion
    epithelial
    homeostasis
    morphogenesis
    cancer cell biology
  15. Utpal Banerjee

    University of California, Los Angeles, United States

    Expertise
    Cancer Biology
    Stem Cells and Regenerative Medicine
    Human Biology and Medicine
    Developmental Biology
    Research focus
    haematopoiesis
    cancer biology
    Experimental organism
    Drosophila
  16. Matthew G. Vander Heiden

    Massachusetts Institute of Technology, United States

    Expertise
    Cancer Biology
    Human Biology and Medicine
    Research focus
    cancer metabolism
    cell metabolism
    metabolic biochemistry
    Experimental organism
    mouse
  17. Elaine Fuchs

    Rockefeller University, United States

    Expertise
    Stem Cells and Regenerative Medicine
    Human Biology and Medicine
    Research focus
    skin stem cells
    stem cells
    tissue morphogenesis
    epithelial polarity
    transcriptional regulation during development
    cytoskeletal dynamics and adhesion
    epithelial cancers
  18. Christine Clayton

    Zentrum fuer Molekulare Biologie der Universitaet Heidelberg (ZMBH), Germany

    Expertise
    Microbiology and Infectious Disease
    Human Biology and Medicine
    Research focus
    trypanosomes
    mRNA degradation
    RNA-binding proteins
  19. Gordana Vunjak-Novakovic

    Columbia University, United States

    Expertise
    Stem Cells and Regenerative Medicine
    Human Biology and Medicine
    Research focus
    cardiac and bone regeneration
    tissue engineering
    in vitro models of development and disease
    biophysical regulation of stem cells
  20. Peter Ratcliffe

    University of Oxford, United Kingdom

    Expertise
    Cell Biology
    Human Biology and Medicine
    Research focus
    cancer
    metabolism
    epigenetics
    cellular biology
    angiogenesis
    hypoxia
    Experimental organism
    human
  21. Michael R Green

    University of Massachusetts Medical School, United States

    Expertise
    Cancer Biology
    Chromosomes and Gene Expression
    Human Biology and Medicine
    Research focus
    RNA splicing
    cancer molecular biology
  22. Milica Radisic

    University of Toronto, Canada

    Expertise
    Human Biology and Medicine
    Research focus
    tissue engineering
    biomaterials
    organ-on-a-chip engineering
    myocardium
    vasculature
  23. David Ginsburg

    University of Michigan, United States

    Expertise
    Human Biology and Medicine
    Genetics and Genomics
    Research focus
    genetics of global gene expression
    mouse models of human disease
    haematology
  24. Gou Young Koh

    Institute of Basic Science and Korea Advanced Institute of Science and Technology (KAIST), South Korea

    Expertise
    Cancer Biology
    Human Biology and Medicine
    Developmental Biology
    Research focus
    angiogenesis
    lymphangiogenesis
    adipogenesis
    cardiogenesis
    vascular and cardiovascular biology
  25. Eunjoon Kim

    Korea Advanced Institute of Science and Technology, South Korea

    Expertise
    Human Biology and Medicine
    Neuroscience
    Research focus
    neurodevelopmental disorders
    synapse development and plasticity
    synaptic transmission
  26. Joseph G Gleeson

    The Rockefeller University, United States

    Expertise
    Human Biology and Medicine
    Neuroscience
    Research focus
    neurodevelopmental disease
    brain development
  27. Ruth Loos

    The Icahn School of Medicine at Mount Sinai, United States

    Expertise
    Epidemiology and Global Health
    Human Biology and Medicine
    Genetics and Genomics
    Research focus
    epidemiology
    obesity and cardiometabolic traits